ASH to honor 6 scientists for treatment of hematologic diseases The American Culture of Hematology , the world’s largest professional society of blood specialists, will honor six scientists who’ve made significant contributions to the treatment and knowledge of hematologic diseases. December 4-7 in Orlando These awards can be presented in the 52nd ASH Annual Meeting occurring. Volker Diehl, MD, of the University of Cologne in Cologne, Germany, will be offered the 2010 Wallace H.In this way we have intrinsic resistant and obtained resistant versions to chemotherapeutic treatment that would have been used in the clinic. These versions therefore show relevant level of resistance phenotype may then be used to recognize new or combination treatments that will specifically target the resistant cancers. How offers this affected the development of second-generation chemotherapeutics? Although the combos of multiple medicines with different mechanisms may improve overall effect the medial side effects would be a limiting factor. In addition, a few of the system of level of resistance may confer simultaneous level of resistance to many other medications causing multi-drug resistance therefore second generation chemotherapeutics may not be effective.